+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novavax Inc - logo

Novavax is a clinical-stage vaccine company that develops recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization, seasonal quadrivalent influenza and pandemic H7N9 vaccines, a vaccine candidate against Ebola Virus and others. Founded in 1987, it is headquartered in Gaithersburg, Maryland.

Vaccine Contract Manufacturing Market (2nd Edition), 2019-2030 - Product Thumbnail Image

Vaccine Contract Manufacturing Market (2nd Edition), 2019-2030

  • Report
  • July 2019
  • 406 Pages
From
Global Covid-19 Vaccine Market - Analysis By Product Type, Patient Type, End User, By Region, By Country (2021 Edition): Market Insights, Competition and Forecast (2020-2030) - Product Thumbnail Image

Global Covid-19 Vaccine Market - Analysis By Product Type, Patient Type, End User, By Region, By Country (2021 Edition): Market Insights, Competition and Forecast (2020-2030)

  • Report
  • March 2021
  • 214 Pages
From
Recombinant Vaccines Market, by Product Type, by Disease Type, by End-user, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 - Product Thumbnail Image

Recombinant Vaccines Market, by Product Type, by Disease Type, by End-user, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

  • Report
  • June 2022
  • 156 Pages
From
COVID-19 (Coronavirus) Global Market Conditions and Competitors: Cell Therapies, Diagnostics, Treatments, Trials, & Vaccines - Product Thumbnail Image

COVID-19 (Coronavirus) Global Market Conditions and Competitors: Cell Therapies, Diagnostics, Treatments, Trials, & Vaccines

  • Report
  • July 2020
  • 269 Pages
From
Global Influenza Vaccines Market 2021 - 2027 - Product Thumbnail Image

Global Influenza Vaccines Market 2021 - 2027

  • Report
  • April 2021
  • 275 Pages
From
Vaccines Market, by Technology, by Type, by Indication, by Route of Administration, by Age Group, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 - Product Thumbnail Image

Vaccines Market, by Technology, by Type, by Indication, by Route of Administration, by Age Group, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

  • Report
  • February 2022
  • 165 Pages
From
Global Preventive Vaccines Market, 2020-2030 - Product Thumbnail Image

Global Preventive Vaccines Market, 2020-2030

  • Report
  • April 2020
  • 248 Pages
From
Vaccine Market By Technology Type, Indication and End User and Geography - Global Forecast up to 2027 - Product Thumbnail Image

Vaccine Market By Technology Type, Indication and End User and Geography - Global Forecast up to 2027

  • Report
  • July 2021
  • 133 Pages
From
Global Influenza Vaccines Market, Persons Vaccinated, Impact of COVID-19, Company Analysis, Size, Share, Growth, Trends, Major Deals - Forecast to 2027 - Product Thumbnail Image

Global Influenza Vaccines Market, Persons Vaccinated, Impact of COVID-19, Company Analysis, Size, Share, Growth, Trends, Major Deals - Forecast to 2027

  • Report
  • July 2021
  • 322 Pages
From
COVID-19 Vaccines - Global Market Trajectory & Analytics - Product Thumbnail Image

COVID-19 Vaccines - Global Market Trajectory & Analytics

  • Report
  • July 2022
  • 762 Pages
From
Coronavirus Vaccine Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027 - Product Thumbnail Image

Coronavirus Vaccine Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  • Report
  • December 2020
From
Vaccine Adjuvants - Global Market Trajectory & Analytics - Product Thumbnail Image

Vaccine Adjuvants - Global Market Trajectory & Analytics

  • Report
  • April 2021
  • 329 Pages
From
Novel Vaccine Delivery Devices Market, 2019-2030 - Product Thumbnail Image

Novel Vaccine Delivery Devices Market, 2019-2030

  • Report
  • November 2019
  • 403 Pages
From
Respiratory Syncytial Virus Infections - Pipeline Insight, 2021 - Product Thumbnail Image

Respiratory Syncytial Virus Infections - Pipeline Insight, 2021

  • Clinical Trials
  • June 2021
  • 60 Pages
From
Global Vaccine Adjuvants Market - Product Thumbnail Image

Global Vaccine Adjuvants Market

  • Report
  • June 2021
  • 243 Pages
From
Coronavirus Disease 2019 (COVID-19) Vaccines - Opportunity Assessment and Forecast to 2026 - Product Thumbnail Image

Coronavirus Disease 2019 (COVID-19) Vaccines - Opportunity Assessment and Forecast to 2026

  • Report
  • June 2021
  • 73 Pages
From
Influenza Vaccine Market Research Report by Vaccine Type (Inactivated, Live Attenuated, and Recombinant), Age Group, Administration Route, Distribution Channel, State - United States Forecast to 2027 - Cumulative Impact of COVID-19 - Product Thumbnail Image

Influenza Vaccine Market Research Report by Vaccine Type (Inactivated, Live Attenuated, and Recombinant), Age Group, Administration Route, Distribution Channel, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • Report
  • July 2022
  • 138 Pages
From
Global Coronavirus Vaccine Market, By Infection Type (SARS-CoV-2, SARS-CoV, MERS-CoV), By Vaccine Type, By Product Type, By Route of Administration, By Patient Type, By End User, By Region, Competition Forecast & Opportunities, 2026 - Product Thumbnail Image

Global Coronavirus Vaccine Market, By Infection Type (SARS-CoV-2, SARS-CoV, MERS-CoV), By Vaccine Type, By Product Type, By Route of Administration, By Patient Type, By End User, By Region, Competition Forecast & Opportunities, 2026

  • Report
  • July 2021
  • 119 Pages
From
Malaria Vaccine Market Research Report by Type (Erythrocytic Vaccine, Multi-antigen Vaccine, and Pre-erythrocytic Vaccine), Agent, End-User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19 - Product Thumbnail Image

Malaria Vaccine Market Research Report by Type (Erythrocytic Vaccine, Multi-antigen Vaccine, and Pre-erythrocytic Vaccine), Agent, End-User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • Report
  • July 2022
  • 145 Pages
From
Malaria Vaccine Market Research Report by Type (Erythrocytic Vaccine, Multi-antigen Vaccine, and Pre-erythrocytic Vaccine), Agent, End-User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19 - Product Thumbnail Image

Malaria Vaccine Market Research Report by Type (Erythrocytic Vaccine, Multi-antigen Vaccine, and Pre-erythrocytic Vaccine), Agent, End-User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • Report
  • July 2022
  • 223 Pages
From
Loading Indicator